Related Experiment Video
Updated: May 29, 2026

Induction of Invasive Transitional Cell Bladder Carcinoma in Immune Intact Human MUC1 Transgenic Mice: A Model for Immunotherapy Development
Published on: October 30, 2013
Bufalin induces apoptosis through activation of both the intrinsic and extrinsic pathways in human
1Department of Biochemistry, College of Oriental Medicine, Research Institute of Oriental Medicine, Dong-Eui University, Busan 614-052, Republic of Korea.
Abstract:
Bufalin, a major digoxin-like immunoreactive component of the Chinese medicine Chansu, is prepared from toad venom. This compound has been shown to exert a potential for anticancer activity against various human cancer cell lines in vitro. However, the detailed molecular mechanisms of its induction of apoptosis are still unclear. In this study, we investigated the apoptosis-inducing effect of bufalin in T24 human bladder cancer cells. Our data revealed that bufalin treatment resulted in a concentration-response growth inhibition of T24 cells by inducing cell cycle arrest at the G2/M phase and apoptosis, as evidenced by formation of apoptotic bodies, chromatin condensation and accumulation of cells in the sub-G1 phase. Apoptosis induction of T24 cells by bufalin showed correlation with proteolytic activation of caspase-3, -8 and -9, and concomitant degradation of poly (ADP-ribose) polymerases, and collapse of the mitochondria membrane potential. In addition, bufalin treatment resulted in an increase of the Bax/Bcl-2 (or Bcl-xL) ratio and caused down-regulation of inhibitor of apoptosis protein (IAP) family members. The increase in apoptosis by bufalin treatment was also associated with up-regulation of death receptor-related factors. Our data indicate that the growth inhibitory effects of bufalin occur through blockade of the G2/M phase, and that these cancer cells do not enter cell cycle progression and die through apoptosis via both intrinsic and extrinsic pathways.
Insights
Bufalin, derived from toad venom, effectively inhibits T24 human bladder cancer cell growth. It induces apoptosis and cell cycle arrest at the G2/M phase through both intrinsic and extrinsic pathways.
Area of Science:
- Pharmacology
- Oncology
- Molecular Biology
Background:
- Bufalin, a component of the Chinese medicine Chansu from toad venom, exhibits potential anticancer activity in vitro.
- The precise molecular mechanisms underlying bufalin's induction of apoptosis remain largely unelucidated.
Purpose of the Study:
- To investigate the apoptosis-inducing effects of bufalin on T24 human bladder cancer cells.
- To elucidate the molecular mechanisms by which bufalin mediates cancer cell death.
Main Methods:
- T24 human bladder cancer cells were treated with varying concentrations of bufalin.
- Analysis included cell cycle progression, apoptosis markers (apoptotic bodies, chromatin condensation, sub-G1 accumulation), caspase activation (caspase-3, -8, -9), PARP degradation, mitochondrial membrane potential, Bax/Bcl-2 ratio, IAP family members, and death receptor factors.
Main Results:
- Bufalin treatment inhibited T24 cell growth in a dose-dependent manner, inducing G2/M cell cycle arrest and apoptosis.
- Apoptosis was mediated by activation of caspase-3, -8, and -9, PARP cleavage, mitochondrial dysfunction, altered Bax/Bcl-2 ratio, and modulation of IAP family members and death receptors.
- Bufalin triggers apoptosis via both intrinsic and extrinsic pathways, blocking cell cycle progression.
Conclusions:
- Bufalin effectively inhibits human bladder cancer cell growth by inducing apoptosis and cell cycle arrest.
- The study clarifies bufalin's anticancer mechanism, involving both intrinsic and extrinsic apoptotic pathways.
- Bufalin represents a promising therapeutic agent for bladder cancer, warranting further investigation.
Related Concept Videos
The Intrinsic Apoptotic Pathway
The Extrinsic Apoptotic Pathway
Apoptosis
Cellular Injury V: Apoptosis and Autophagy
Caspases